Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016444 · ClinicalTrials.gov registry record
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
A clinical trial, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- 311
- Enrollment target
NCT01016444: Completed study, sponsored by MetroHealth Medical Center.
NCT01016444 is a clinical trial that has completed, run by MetroHealth Medical Center. The registered enrollment target is 311 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01016444 has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- 311 participants
- Enrollment target
Study Summary
The hypothesis to be tested is that acutely ill asthmatics who do not resolve their attacks following standard doses of albuterol and require admission to hospital have single nucleotide polymorphisms of their B2 adrenergic receptors that lower B2 agonist responsivity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-07-29 |
What the finished NCT01016444 record still lists
NCT01016444 is an observational study that tracks outcomes without assigning an intervention. The registered 311 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01016444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01016444 about?
NCT01016444 is a clinical study titled "Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms". The hypothesis to be tested is that acutely ill asthmatics who do not resolve their attacks following standard doses of albuterol and require admission to hospital have single nucleotide polymorphisms of their B2 adrenergic receptors that lower B2 agonist responsivity.
What is the current status of trial NCT01016444?
This trial is currently completed. The enrollment target is 311 participants. The study started on 2009-12. Estimated completion is 2011-07-29.
Who is sponsoring clinical trial NCT01016444?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia